Functional studies have reported that miR-483-3p may act as an oncogene by targeting BBC3/PUMA directly [14] or tumor suppressor via repression of multiple targets including CDC25A, BIRC5, and RAN [37]. This evidence concerns the gene CDC25A and neoplasm.